Macasasa, Arlene S.

HRN: 26-91-50  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/21/2025
CEFTRIAXONE 1G (VIAL)
08/21/2025
09/04/2025
IVTT
2g
OD
Infected Wound
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines